Lotra Tablets (Glimipiride)
Glimepiride 2mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.
MFDS item code 200402453 · Notified 2004.02.06 · Insurance code 644700410
This product's status changed to Approval withdrawn on 2025.12.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes in conjunction with dietary and exercise regimens. It can be administered alone and is also effective when used in combination with oral hypoglycemic agents or insulin in cases where blood sugar control is difficult. Particularly in cases where sulfonylureas or metformin therapy is insufficient, it is used in combination with metformin to enhance blood sugar control. This medication plays a crucial role in comprehensive blood sugar management and diabetes treatment.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this drug orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional effect with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this drug required may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at 1 ~ 2 week intervals. Consider the potency and duration of action of the previous medication. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this drug, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. Generally, hypoglycemia can be controlled immediately by taking sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to identify the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Patients who have had allergic reactions to this medication or its components, as well as others in the same class, should avoid use. It is recommended to switch to insulin treatment for patients with severely impaired liver or kidney function. It is also advisable for women who are pregnant or may become pregnant, as well as nursing mothers, to avoid using this medication. Insulin treatment may be more appropriate for patients with severe infections, perioperative status, or significant trauma. Caution is advised if gastrointestinal disturbances may hinder food absorption, increasing the risk of hypoglycemia. During the first week of starting this medication, the risk of hypoglycemia is heightened, and blood sugar levels should be closely monitored. Particular precautions should be taken for the elderly, individuals with poor nutritional status or irregular eating habits, imbalances in exercise and diet, changes in eating patterns, and frequent alcohol consumption. Patients with compromised kidney or liver function may also respond more sensitively to this medication, necessitating dose adjustments. Furthermore, those with other endocrine disorders or taking multiple medications should consult a doctor, as the risk of hypoglycemia may increase. When using this medication, one should be aware of possible hypoglycemic symptoms such as headaches, severe hunger, nausea, fatigue, confusion, dizziness, drowsiness, and decreased consciousness. It is critical to consume carbohydrate-containing foods immediately if hypoglycemic symptoms occur. Some patients may experience temporary blurred vision or gastrointestinal symptoms, as well as abnormalities in liver function, blood changes, or allergic reactions. Serious allergic reactions such as urticaria or difficulty breathing require immediate medical attention. This medication must be used alongside dietary and exercise regimens for blood sugar control and should be taken regularly. To prevent hypoglycemic symptoms, it is advised to always carry carbohydrates and ensure that family members are aware of hypoglycemia symptoms and treatment methods. In stressful situations or after surgery or infections where blood sugar control becomes challenging, transitioning to insulin therapy may be necessary. This medication can interact with other medications, so it is essential to inform your doctor or pharmacist of any other drugs being taken. Particularly, changes in blood sugar levels may occur when taken with certain antibiotics, antifungals, antihypertensives, anticoagulants, and beta-blockers. It is safest for pregnant or nursing women to avoid this medication, and insulin treatment should be considered if necessary. In cases of overdose, severe hypoglycemia can occur, necessitating immediate medical assistance and observation in a hospital until blood sugar levels are fully restored. This medication should be kept out of the reach of children, stored in its original container, and taken precisely as directed by a physician.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, perceptual abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, neurological seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, sensation of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, gustatory disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to store it at room temperature, ideally between 1 and 30 degrees Celsius.
Green rectangular tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 2mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.